After one month , the percentage of improvement was less in the PRP than bupivacaine group in terms of the VAS for pain ( 17.7 % vs. 26.5 % ) , MMCPIE score ( 24.0 % vs. 27.6 % ) , and Nirschl score ( 20.7 % vs. 31.1 % ) .